NEW YORK (360Dx) — Alere said yesterday that it has appealed a decision by the Centers for Medicare and Medicaid Services (CMS) to revoke the Medicare billing privileges of the diagnostic company's diabetes unit, Arriva Medical.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.